THE EFFECT OF METABOLIC ACTIVATORS ON THE EXPERIMENTAL CEREBROVASCULAR DISEASE.
D000255:Adenosine Triphosphate; D000818:Animals; D002543:Cerebral Hemorrhage; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders; D003580:Cytochromes; D004285:Dogs; D005492:Folic Acid; D006653:Histology; D020766:Intracranial Embolism; D002542:Intracranial Embolism and Thrombosis; D008660:Metabolism; D009525:Niacin; D009539:Nicotinic Acids; D012106:Research; D013835:Thiamine Pyrophosphate; D008063:Thioctic Acid; D014803:Vitamin B Complex
D003580:Cytochromes; D009539:Nicotinic Acids; D014803:Vitamin B Complex; D009525:Niacin; D008063:Thioctic Acid; D000255:Adenosine Triphosphate; D005492:Folic Acid; D013835:Thiamine Pyrophosphate
ADENOSINE TRIPHOSPHATE; CEREBRAL EMBOLISM AND THROMBOSIS; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; CYTOCHROMES; DOGS; EXPERIMENTAL LAB STUDY; HISTOLOGY; LIPOIC ACID; METABOLISM; NICOTINIC ACID; THIAMINE PYROPHOSPHATE; VITAMIN B COMPLEX